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When 3T3-F442A preadipocytes were grown in culture media supplemented with corticosteroid poor fetal 
calf serum and insulin they differentiated into adipocytes. Glycerophosphate d hydrogenase, a marker of 
terminal differentiation, developed a 600-fold increase of activity whereas the adenylate cyclase system 
remained unresponsive to the synthetic ACTH(1-24) analog. In contrast, 3T3-F442A adipocytes, differ- 
entiated in the presence of dexamethasone, exhibited an adenylate cyclase activity which was stimulated 
4-fold by ACTH(1-24). The stimulation of the adenylate cyclase activity by GTPyS remained unchanged 
(about 20-25-fold) suggesting that the G regulatory coupling protein was not functionally modified by dexa- 
methasone. Binding studies with t25I-ACTH revealed that specific cellular binding could be evidenced in 
dexamethasone-treated cells while control adipocytes did not exhibit any specific binding of 125I-ACTH. 
These findings lend support o the hypothesis that the setting off of this ACTH responsiveness in 3T3-F442A 
cells is regulated by dexamethasone after cells are committed to adipose differentiation. 
Dexamethasone; Adenylate cyclase; ACTH receptor; Differentiation; (3T3 preadipocyte) 
1. INTRODUCTION 
The physiological responsiveness of highly 
specialized and terminally differentiated cells is 
conditioned by environmental conditions namely 
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Abbreviations: GTPyS, guanosine 5'-(3-O-thio)triphos- 
phate; ACTH(1-24), synthetic tetracosapeptide (1-24) 
of adrenocorticotropic hormone; G/F(Gi, Gs, Go) the 
regulatory component of adenylate cyclase which ap- 
pears to be a site of action of guanine nucleotides 
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(EC 4.6.1.1); creatine phosphokinase or ATP : creatine 
N-phosphotransferase (EC 2.7.3.2); glycerophosphate 
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concerted interactions with hormones during in 
vivo tissue development. Murine 3T3 preadipocyte 
cell lines [1-3] which exhibit an increased hormone 
sensitivity during their differentiation cycle [4-6] 
are especially suitable cell models for studying the 
assembly of the hormonally sensitive adenylate 
cyclase system during in vitro adipose conversion. 
While 3T3 cell subclones are not able to differen- 
tiate in defined media [5,7], the complexity of sera 
used for cell culture and differentiation renders it 
difficult to elucidate the biochemical events 
underlying hormonal interactions in these cells. In 
this paper special interest is focused on the fac- 
tor(s) that regulate(s) the development of ACTH 
responsiveness of the adenylate cyclase system dur- 
ing adipose conversion of 3T3-F442A cells. We 
demonstrate that dexamethasone, a synthetic 
glucocorticoid analog, sets off  the ACTH(1-24)  
responsiveness of the adenylate cyclase system dur- 
ing adipose conversion of 3T3-F442A cells in 
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culture medium supplemented with steroid- 
depleted fetal calf serum. These changes in the 
coupling properties of ACTH(1-24)-stimulated 
adenylate cyclase could be related to the 
modulating effect of dexamethasone on the 
specific cellular binding of 125I-ACTH. The effi- 
ciency of the guanine nucleotide regulatory protein 
responsible for activation of adenylate cyclase is 
not modified by chronic exposure of cell cultures 
to dexamethasone. All these events are linked both 
to the cell's commitment to differentiation and to 
the presence of dexamethasone but are unrelated 
to terminal differentiation since mature 
adipocytes, unresponsive to ACTH(1-24), can be 
obtained in the absence of the drug. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
3T3-F442A and 3T3-C2 were generously provid- 
ed by Dr Howard Green (Harvard Medical School, 
Boston). Cells were grown in 100 mm dishes 
(Falcon or CEB) in Dulbecco-Vogt modified 
Eagle's medium (DMEM) supplemented with 10070 
fetal calf serum and insulin (5/~g/ml) from the 
confluence. Most of the experiments were per- 
formed with fetal calf sera obtained from Boeh- 
ringer (lot no.071) and Flow Laboratories (lot 
n~.036066). These sera were chosen for their low 
content of corticosteroid: less than 5 ng/ml ex- 
pressed in cortisol and monitored by radiocom- 
petitive assays using human transcortine and they 
did not need further desteroidation before use. In 
some experiments, cells were grown in DH/4F 
medium [8] consisting of a mixture of DMEM and 
Ham-F12 (2: 1, v/v) supplemented with 5/~g/ml 
insulin, 5/~g/ml transferrin, 2/~g/ml luteinizing 
hormone and 10/~g/ml submaxillar gland extract. 
At the indicated period, cell cultures were washed 
twice with cold phosphate buffered saline, 
homogenized in 1 mM dithiothreitol, 25 mM Tris- 
HCI buffer (pH 7.5) in a Dounce homogenizer. 
Homogenates were centrifuged at 10000 × g (4°C) 
and pellets resuspended in the homogenization 
buffer at a concentration of 5-10 mg protein/ml. 
Proteins were assayed according to Lowry et al. [9] 
using bovine serum albumin as a standard. Control 
adipocytes yielded approx. 0.33 mg of membrane 
protein per 10 6 cells, while dexamethasone-treated 
adipocytes yielded 0.25 mg of membrane protein 
per 10 6 cells. 
2.2. Enzyme assays 
Adenylate cyclase activity was assayed in 
triplicate for 10 min at 35°C in a 50/A reaction 
mixture containing 0.2 mM [o~-32p]ATP (1/~Ci), 
1 mM cyclic AMP, l0 mM creatine phosphate, 0.5 
unit creatine phosphokinase, 5 mM MgCI2, 
0.2 mM dithiothreitol, 100 mM Tris-HC1 (pH 
7.5). Reaction was initiated by the addition of 
membranes (about 25/~g protein) and cyclic 
[32p]AMP was isolated and counted as described 
[51. 
Glycerophosphate dehydrogenase activity was 
assayed by recording the initial rate of oxidation of 
NADH at 340 nm at 25°C [10]. The standard mix- 
ture contained 50 mM triethanolamine-HC1 buffer 
(pH 7.5), 1 mM EDTA, 0.13 mM NADH, l mM 
dihydroxyacetone phosphate, 1 mM 2-mercapto- 
ethanol and variable amounts of cell supernatant 
(10000 × g). 
2.3. ACTH receptors 
~25I-ACTH binding studies were performed 
directly in cell cultures (60 mm dishes) previously 
washed and kept overnight in serum-free DMEM 
supplemented with l mg/ml bovine serum albumin 
(BSA). Samples (about 2 to 3 × l0  6 cells) for 
60 mm dishes were incubated with gentle shaking 
in triplicate for 30 min at 25°C in 1 ml DMEM 
buffered with 20 mM Hepes (pH 7.35), containing 
aprotinin (1 mg/100 ml), soybean trypsin inhibitor 
type II (10 mg/100 ml), bacitracin (100 mg/ 
100 ml), 1°70 BSA and 0.2 nM (3-[125I]iodotyro - 
sylZ3)ACTH(1-39) (spec. act. 68 TBq/mmol) 
(Amersham International). Non-specific binding 
was determined with 2/zM unlabeled ACTH(1-24) 
(Bachem) and accounted in about 60°7o f the total 
binding. At the end of the incubation, cells were 
rinsed three times with ice-cold phosphate buffered 
saline and collected in 0.5O7o SDS for the deter- 
mination of radioactivity. Results were normalized 
to cell number; the latter was determined from 
parallel dishes, after harvesting the cells with tryp- 
sin and scoring in a hematocytometer. 
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3. RESULTS 
3.1. The development of  A CTH(1-24) 
responsiveness of 3T3-F442A cells is 
dependent on dexamethasone 
Adipogenic differentiation of 3T3-F442A cells 
in surface cultures involves a change from a 
fibroblastic morphology (growing state) to an 
enlarged rounded cell shape (resting state); the ter- 
minal maturation process is characterized by the 
accumulation of abundant lipid vesicles, especially 
in the presence of insulin. 
Recently, we demonstrated that dexamethasone 
could p~vent erminal maturation of F442A cells 
and that insulin counteracted its inhibitory effect 
[11]. Thus, in insulin supplemented culture 
medium dexamethasone elicited only discrete mor- 
phological changes such as acceleration of the 
rounding up of the cells; cell plasma membranes 
were looking thicker and lipid droplets were 
smaller than in control cultures. 
Terminal maturation of F442A adipocytes did 
not depend on the batch of fetal calf serum used 
for cell cultures; on the contrary we observed that 
ACTH responsiveness of the adenylate cyclase ac- 
tivity of the adipocytes could vary, according to 
the serum, within the range of 20-400°7o increase 
over basal activity (at day 8 after confluence). 
Thus, cells were allowed to differentiate in the 
presence of serum which was previously absorbed 
on dextran-charcoal to remove the steroids. 
Adipocytes differentiated in the native serum ex- 
hibited a 4-fold stimulation of their adenylate 
cyclase activity in the presence of ACTH( I -24)  
and no significant change was observed after addi- 
tion of dexamethasone; otherwise their counter- 
Table 1 
Dexamethasone d pendence of the ACTH(1-24)-stimulated a enylate cyclase activity 
Serum Dexamethasone 
(nM) 
Adenylate cyclase activity 
pmol cyclic AMP. min- 1 , 
(mg protein)- 
Basal ACTH(I-24) 
1/zM 
Ratio 
basal/ACTH(1-24) 
Native none 2.20 9.45 4.3 
250 2.35 11.00 4.7 
Deprived 
of steroids 0 1.50 2.30 1.5 
10 0.65 1.00 1.6 
100 1.45 3.65 2.5 
250 1.80 4.40 2.4 
1000 1.30 3.70 2.8 
3T3-F442A cells were seeded in DMEM supplemented with a mixture of 9°70 calf serum and 
1070 of the mentioned fetal calf serum. 1 day before confluence insulin (5/zg/ml) was added 
and cultures continued in DMEM supplemented with 10°70 of respective sera. On day 2 after 
confluence dexamethasone was added at the indicated concentration. On day 10 crude 
membranes were prepared and assayed for adenylate cyclase activity. Fetal calf serum (batch 
11 H 786) was supplied from Filorga (Paris) and deprived of steroids by dextran-charcoal 
absorption. The latter was performed three times with 10 mg/ml of activated charcoal 
(Merck) and 1 mg/ml of dextran T70 (Pharmacia) for 45 min at 50°C; at the end of each 
cycle the serum was clarified by centrifugation (10000 x g at 4°C for 10 min) and finally 
filtered through glass fiber and 0.22/zm membrane. The content of corticosteroid of the 
native serum was 30 ng/ml (expressed in cortisol); the deprived serum contained an 
undetectable vel of corticosteroids 
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parts grown in steroid deprived serum were very 
poorly sensitive to the hormone (only 50% increase 
over basal activity (table 1)) and the addition of 
dexamethasone to a cell culture medium deprived 
of steroids allowed the cells to recover about 60°70 
of their ACTH responsiveness a  compared to con- 
trol cells (table 1). Thus these initial studies sug- 
gested that dexamethasone was the agent 
responsible for the acquisition of ACTH respon- 
siveness of the adenylate cyclase system. The 
following experiments were performed using 
corticosteroid-poor fetal calf sera which contained 
less than 5 ng of corticosteroid per ml. 
The time course of the development of the 
adenylate cyclase activity was measured in partially 
purified membranes prepared from differentiating 
3T3-F442A cells. No increase of adenylate cyclase 
activity by the ACTH(1-24)  analog could be 
measured in membranes from undifferentiated 
cells (day 0) and during adipocyte development 
control membranes exhibited only a very poor in- 
crease of activity due to ACTH(1-24)  (2507o about 
over basal activity) (fig.l). In contrast he activa- 
tion of adenylate cyclase activity by ACTH(1-24)  
increased markedly when measured in membranes 
from cells treated with 0.25/,M dexamethasone 
from confluence (day 0) reaching a maximum 
value by day 8 (fig.l). Typically 3T3-F442A 
adipocytes differentiated in the presence of dex- 
amethasone possessed an adenylate cyclase system 
which was stimulated about 4-fold over basal ac- 
tivity by ACTH(1-24)  at a maximal concentration 
of 10/~M. Otherwise adenylate cyclase of 
3T3-F442A preadilx)cyte membranes (day 0) was 
highly sensitive to GTPTS alone (20-fold over 
basal activity) and this responsiveness remained 
unchanged uring adipocyte development whether 
dexamethasone was present or not (fig.l). 
The expression of a sensitive marker of terminal 
differentiation [12,13] indicated a 300- and 
600-fold increase of enzyme activity respectively in
the presence and absence of the drug (table 2). In 
parallel, 3T3-F442A cells grown in serum-free 
DH/4F  medium and undifferentiating 3T3-C2 cell 
subclone which both retain the characteristics of 
fibroblasts during prolonged maintenance in 
culture as confluent monolayers did not exhibit 
any enzyme markers of adipose differentiation; 
furthermore no effect of dexamethasone could be 
evidenced (table 2). 
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Fig.l. Development of ACTH(I-24) and GTPyS- 
stimulated adenylate cyclase activity of dexametha- 
sone-treated 3T3-F442A cells. 3T3-F442A cells were 
grown to confluence (day 0) in DMEM supplemented 
with 10% fetal calf serum and insulin, 5/~g/ml. At day 
0, dexamethasone (0.25/~M) was added to some cultures 
and crude membranes were prepared at the indicated 
time. Basal and stimulated adenylate cyclase activities 
were assayed as described in section 2 in the presence of 
10/~M ACTH(1-24) for control (zx A) and dexameth- 
asone-treated cells ('- -') or in the presence of l0/2M 
GTPTS for control (o - -o )  and dexamethasone-treated 
cells (;  ;). Results are expressed as the ratio of 
stimulated activity over basal activity which represents 
the hormone receptor coupling efficiency. Values of 
basal adenylate cyclase activity were 3.5, 3, 5.8 and 
10.4 pmol cyclic AMP. min- ]- (mg protein)- l 
respectively atday 0, 4, 8 and 12 for control and 2.0, 4.4 
and 4.8 pmoi cyclic AMP.min- t-(mg protein)-l 
respectively at day 4, 8 and 12 for dexamethasone- 
treated cells. 
3.2. Dexamethasone regulates the phenotypic 
expression of adenylate cyclase activity 
according to the developmental stage of the 
cells 
The possibility has been investigated that the ef- 
fect of dexamethasone could depend on its time of 
addition to the developmental cycle of the 
adipocyte. Short term exposure to dexamethasone 
(48 h) was performed at different stages of dif- 
ferentiation starting from day 0 (confluence) up to 
day 18 on terminally differentiated adipocytes. 
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Table 2 
Effect of dexamethasone on the adenylate cyclase and glycerophosphate dehydrogenase activities of 3T3 
cells grown in different culture conditions 
Cell Culture Cell phenotype Addition a Adenylate Glycerophosphate 
subclone conditions (day after cyclase dehydrogenase 
confluence) 
Basal ACTH(1-24) 
1 ,aM 
3T3-F442A 10% FCS b 
DH/4F 
preadipocyte 
(day 0) none 3.5 3.0 2.0 
adipocyte none 5.8 6.0 1220 
(day 8) dexamethasone 4.4 13.7 625 
preadipocyte none 1.3 1.4 2.6 
(day 8) dexamethasone 0.9 0.8 3.0 
3T3-C2 10% FCS fibroblast none 2.7 2.1 0.5 
(day 8) dexamethasone 3.7 3.2 0.5 
a Dexamethasone added at confluence at a concentration of 0.25 `aM 
b Corticosteroid content of the serum was less than 5 ng/ml 
Growth and differentiation of 3T3 cells were performed in DMEM supplemented with 10o70 fetal calf 
serum (FCS) and insulin (5 ` ag/ml) or serum-free medium (DH/4F) (see section 2). Adenylate cyclase and 
glycerophosphate dehydrogenase activities were determined at the indicated times and expressed in pmol 
cyclic AMP. min- ~. (mg protein)- l and nmol NADH oxidized, min i. (mg protein)- l, respectively 
After  2 days of  exposure to the drug crude mem- 
branes were prepared;  the kinetics of  the ap- 
pearance of  ACTH(1-24)  st imulated adenylate 
activity was biphasic (fig.2). The maximal  efficien- 
cy of  the dexamethasone effect was obtained by 
treatment of  3T3-F442A cells between day 2 and 
day 4 leading to a 4-fold st imulat ion of  the 
adenylate cyclase activity in response to a maximal  
concentrat ion of  ACTH(1-24) .  Then there was a 
progressive relaxation of  the dexamethasone ef- 
fect; only a 60o7o increase of  adenylate cyclase ac- 
tivity due to the hormone was observed when the 
drug was added to adipocytes cultures between day 
16 and day 18 (fig.2). In the same interval of  t ime 
control  cultures of  3T3-F442A adipocytes,  which 
were not exposed to dexamethasone,  xhibited a 
very low ACTH(1-24) -s t imulated  adenylate 
cyclase activity (20-30o7o over basal) (fig.2). 
Fig.2. Variation of the ACTH(I-24) sensitivity of the 
adenylate cyclase system after short term exposure of 
F442A cells to dexamethasone at different periods of 
4 
® m 
~E 
m A  
IEk!A ~l~exametha sOne 
control 
-I 0 I I I I 5 I0 15 20 
Days of ¢ulture after  ¢onfluen¢e 
their differentiation. Starting from confluence, cultures 
of 3T3-F442A cells were sequentially exposed to 
dexamethasone (0.25`aM) for 2 days (m)  at 
different stages of the differentiation process. Then 
crude membranes were prepared and adenylate cyclase 
activity was assayed in the absence and presence of 
10`aM ACTH(1-24) for both control (zx A) cells and 
dexamethasone-treated cells (-" -*). Hormone receptor 
coupling is expressed by the ratio of stimulated activity 
over basal activity. 
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3.3. Steroid specificity of the appearance of 
ACTH(1-24)-stimulated adenylate cyclase 
activity during adipose differentiation 
To examine the specificity of  steroids for the ac- 
quisition of  ACTH(1-24)-st imulated adenylate 
cyclase activity 3T3-F442A cells were differen- 
tiated in the presence of  various steroids. 
Aldosterone and to a lesser extent progesterone 
were the only two non-glucocorticoids that 
mimicked a part of  the biological response of  
adipocytes to dexamethasone; estradiol and 
testosterone were not effective at all (table 3). 
3.4. Dexamethasone promotes the increase of 
adrenocorticotropin receptors during 
adipogenic differentiation 
Binding experiments of  ACTH(1-39)  were con- 
Table 3 
Steroid specificity of the induction of ACTH(I-24) 
sensitivity of the adenylate cyclase system in 3T3-F442A 
cells 
Steroid Concen- ACTH(l-24)-stimulated 
tration adenylate cyclase 
(nM) 
Stimulated/ % of 
basal control 
None - 1.5 0 
Dexamethasone 250 3.7 100 
Aldosterone 10 1.4 0 
100 2.2 31 
1000 3.9 107 
Progesterone 100 1.4 0 
1000 2.7 52.5 
Testosterone 100 1.6 2 
1000 1.5 1 
Estradiol 100 1.2 0 
1000 1.4 0 
Cells were grown in DMEM supplemented with 10% of 
corticosteroid poor fetal calf serum (Flow Laboratories, 
batch 030066 containing less than 5 ng of corticosteroid 
per ml). Insulin, 5/zg/ml, was added at confluence and 
one day later medium was supplemented with the 
different steroids at the indicated concentration. 10 days 
later crude membranes were prepared and adenylate 
cyclase activity was determined as detailed in section 2 in 
the absence (basal) or presence of ACTH(I-24) at 1/zM 
ducted with specifically monoiodinated ACTH at 
tyrosine residue 23, leaving tyrosine 2 unmodified; 
this compound exhibited, like ACTH( I -24)  [14], 
the full potency and spectrum of  biological activi- 
ty. Specific binding of  ~25I-ACTH(1-39) to the 
3T3-F442A fat cells was rapid at room temperature 
(22°C). Binding of  tracer at the concentration of  
0.2 nM reached saturation within 30 min and then 
plateaued (not shown). A displacement curve is 
represented in fig.3 (upper panel) giving a half- 
maximal concentration of  inhibition of  binding of  
IN  
J3 
:1o • 
$ 
t /  ' ® , ,o ,oo ,~  
ue~ 
aT  
, 
" ~ ' J  1 ,o 
A¢ T X [I-=4) nM 
Fig.3. Correlation between ACTH binding and 
ACTH(l-24)-stimulated adenylate cyclase activity in 
dexamethasone-treated 3T3-F442A adipocytes. 3T3- 
F442A adipocytes were differentiated for 8 days after 
confluence in DMEM supplemented with 10% fetal calf 
serum, 5 ~g/ml insulin and when specified with 0.25 ~M 
dexamethasone. (A) Dexamethasone-treated cells (2.1 x 
106 cells per 60 rain dish) were incubated with 125I- 
ACTH and various concentrations of ACTH(1-24) as 
described in section 2; Scatchard plot of the data was 
derived from a linear least squares analysis (inset). (B) 
Dose-response curve for ACTH(1-24)-stimulated 
adenylate cyclase activity of membranes from control 
(A 4) and dexamethasone-treated c lls ( ;  -"). 
Values for basal activities were 1.7 and 2.1 pmol cyclic 
AMP. rain -1. (rag protein)-' respectively in control and 
dexamethasone-treated cells. 
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4 nM. When plotted according to Scatchard (fig.3, 
inset) a single class of binding sites is evidenced 
representing 2.7 fmol ACTH bound per 10 6 cells 
(about 1600 receptors per cell). We could estimate 
a Ko value of 4.5 nM which should be compared to 
the value for half-maximal activation of the 
adenylate cyclase (Ka = 15 nM) (fig.3, lower 
panel). Attempts were made to characterize 1251- 
ACTH binding sites in 3T3-F442A adipocytes dif- 
ferentiated in the absence of dexamethasone; no
specific cellular binding was observed so that, if 
present, the number of ACTH receptors in these 
cells is probably very low (not shown), reflecting 
the poor sensitivity of the adenylate cyclase system 
of these cells (fig. 1). 
4. DISCUSSION 
Until now, glucocorticoid manipulation by 
adrenalectomy of rats and/or dexamethasone ad- 
ministration had led to erratic and sometimes con- 
troversial results concerning the effect of these 
hormones on adipocyte corticotropin receptors 
and adipocyte responses [15-19]. Moreover, the 
differences observed between these studies raised 
questions as to whether glucocorticoid hormones 
had direct effects or whether some aspects of their 
physiological role were mediated by changes in 
counterregulatory hormones or metabolites. 
In this respect, the use of cell models in cultures 
can circumvent his difficulty; thus, 3T3-F442A 
preadipocytes provide an attractive xperimental 
system for studying the molecular basis of the 'per- 
missive' effect of glucocorticoids in allowing the 
full expression of the ACTH-induced cellular 
response, namely the lipolytic one mediated via 
cyclic AMP production. 
In the present study, we demonstrate that the 
stimulation of this dexamethasone modulated 
ACTH(1-24) sensitivity of the adenylate cyclase 
system requires both the cell's commitment to dif- 
ferentiation and the presence of dexamethasone; it 
does not take place in 3T3-F442A cells grown in 
serum free medium and dexamethasone tr atment 
of undifferentiating 3T3-C2 cells is not efficient 
(table 1). Our findings demonstrate that the 
development of adipocyte response to cor- 
ticotropin is not necessarily linked to terminal 
maturation of these cells since differentiated 
adipocytes do not exhibit any ACTH sensitivity as 
long as they are not exposed to dexamethasone. 
These results also demonstrate the independent 
control of the hormone-sensitive adenylate cyclase 
assembly and late lipogenic enzyme expression 
during adipose differentiation. 
The guanine nucleotide-binding protein complex 
is a focal point in hormonal activation of the 
adenylate cyclase system (review [20]). GTPTS, a 
non-hydrolysable analog of GTP, elicits a constant 
activation of the enzyme all along the adipocyte 
development (fig.l). Thus, dexamethasone does 
not functionally modify the G regulatory complex 
of the adenylate cyclase. However we cannot otal- 
ly exclude the fact that dexamethasone induces the 
biosynthesis of a specific, unknown macromolecu- 
lar component that would selectively modify the 
sensitivity of adenylate cyclase to ACTH( l -24) .  
For instance in the related 3T3-L1 preadipocyte 
cell line, previous studies have already indicated 
that changes in hormone receptors or in Gs could 
not account by themselves for increased adenylate 
cyclase response to catecholamines [6,21] so that 
changes in Gi and a novel Go protein subunit have 
been suggested [22]. In the 3T3-F442A cell sub- 
clone, the situation seems to be less complex; the 
increased fl-adrenergic responsiveness of the 
adenylate cyclase system of these cells can be solely 
explained by an increased number of fl-adreno- 
receptors linked to the adipose conversion [5]. 
Specific cellular binding of I25I-ACTH is only 
observed in dexamethasone-differentiated dipo- 
cytes but remains undetectable in preadipocytes 
and control adipocytes. Even though our study 
does not deal with endocytosis and recycling of 
receptors which are quite possible in experiments 
performed at room temperature, the most obvious 
interpretation of our findings is that the induction 
of responsiveness to ACTH(1-24) in differen- 
tiating 3T3-F442A cells could be accounted for 
primarily by the appearance of cell receptors in 
response to dexamethasone. [In parallel we have 
demonstrated that dexamethasone prevents the in- 
crease of~-adrenergic receptor number in fully dif- 
ferentiated cells with insulin. Using the hydrophilic 
antagonist, ritiated CGP-12177, we have estimat- 
ed that the cell surface density of H-receptors in 
dexamethasone-treated cells is 4-6-fold less than 
in control differentiated cells; thus a strict correla- 
tion has been found with the decrease of iso- 
proterenol responsiveness of the adenylate cyclase 
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system of these cells (F~ve, B. and Pairault, J., in 
preparation).] The number of ACTH sites reaches 
1600 receptors per cell with a Kd of 4.5 nM in dexa- 
methasone differentiated adipocytes (fig.3). The 
concentration of dexamethasone cessary to elicit 
ACTH responsiveness of 3T3-F442A adipocytes i
much lower than that of aldosterone and proges- 
terone while other steroids are inefficient (table 3). 
These results suggest hat the regulation of ACTH 
receptors coupling could be mediated through glu- 
cocorticoid receptor; a 4-fold increase of glucocor- 
ticoid receptor has been recently evidenced uring 
adipose conversion of 3T3-F442A cells [23]. 
As proposed by Rubin et al. [24], dex- 
amethasone is commonly used in association with 
insulin and 3-isobutyl-l-methylxanthine to pro- 
mote the differentiation of the related 3T3-L1 
preadipocyte cell line. In these differentiating 
3T3-L1 cells dexamethasone has been already 
shown to elicit a/5'1 to ~'2 switch of ~-adrenergic 
receptor subtypes [25] and to mimic some aspects 
of insulin resistance including both receptor and 
postreceptor defects [26]. From our studies, it is 
probable that the appearance of ACTH receptors, 
evidenced in 3T3-LI adipocytes by Grunfeld et al. 
[27], is linked to the presence of dexamethasone in 
the differentiation protocol used by these authors. 
Thus, in 3T3 preadipocytes, dexamethasone may 
have pleiotypic effects which lead to cell 
phenotypes exhibiting various hormonal respon- 
siveness. 
Otherwise glucocorticoid hormones have been 
shown to have physiological actions on multiple 
cellular processes; thus, the indirect, so-called 'per- 
missive' actions may involve the modulation of the 
affinity and/or  receptor concentrations of a varie- 
ty  ot ~ heterologous hormone and growth factor 
receptors [28-40]. So, given the data presented in 
this paper, ACTH could regulate its own receptor 
in adipocytes early during adipose tissue formation 
via glucocorticoid secretion from the adrenal 
gland; thus a dual effector mechanism of ACTH 
action should be retained to render an account of 
the biological response of the adipose cell to this 
hormone. 
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